Safety of Early Bevacizumab Administration after Central Venous Port Placement for Patients with Colorectal Cancer

Safety of Early Bevacizumab Administration after Central Venous Port Placement for Patients with Colorectal Cancer

Bevacizumab (BEV) requires an adequate withdrawal period to avoid BEV-related complications during major surgery. However, the safety of BEV administration immediately after surgical placement of the central venous (CV) port, a minor surgery, is still unclear. This study aimed to investigate whether...

Full description

Bibliographic Details
Main Authors: Hirona Shigyo, Hiroyuki Suzuki, Toshimitsu Tanaka, Etsuko Moriyama, Yasutaka Shimotsuura, Sachiko Nagasu, Hideki Iwamoto, Yoshito Akagi, Kenta Murotani, Takumi Kawaguchi, Keisuke Miwa
Format: Article
Language:English
Published: MDPI AG 2023-04-01
Series:Cancers
Subjects:
central venous port
bevacizumab
complication
wound healing
colorectal cancer
Online Access:https://www.mdpi.com/2072-6694/15/8/2264

Internet

https://www.mdpi.com/2072-6694/15/8/2264

Similar Items